Multiple Myeloma — An Interview with Dr Surbhi Sidana on Optimizing the Role of CAR T-Cell Therapy (Companion Faculty Lecture)

Featuring a slide presentation and related discussion from Dr Surbhi Sidana, including the following topics:

• Key clinical data of FDA-approved chimeric antigen receptor (CAR) T-cell therapies (0:00)
• Real-world evidence evaluating utility of CAR T-cell therapies in the clinic (8:08)
• Impact of prior BCMA-targeted treatment on CAR T-cell therapy efficacy (12:55)
• Investigational CAR T-cell therapies in clinical development (15:08)
• Incidence and management of toxicities associated with CAR T-cell therapy (18:21)

CME information and select publications